Lown Institute intern Emily Acker has had more interactions with the health care system than the typical young adult. Here's how that has informed her experience as a public health advocate and researcher. More
After an editor at a major medical journal dismissed the idea of structural racism, researchers say his views are symptomatic of larger problems in health research. More
A recent study looks at patterns of charity care spending at public, private, and for-profit hospitals, and finds some interesting results... More
Stopping harmful medications sounds simple, but it can be much harder in practice. How can we take what we've learned from deprescribing trials and scale them up? Dr. Justin Turner explains in a webinar hosted by the US Deprescribing Research Network. More
In a recent piece in the BMJ, Shannon Brownlee and Deborah Korenstein argue that if we want to move the needle overuse, we have to make overuse an issue of preventable harm, not just waste. More
Two recent studies in JAMA find that hospitals and clinicians caring for high proportions of people of color get punished in our current value-based payment programs. More
There's nothing wrong with paying a hospital leader for doing a good job, especially in a crisis. But when compensation goes into the millions we have to ask, are we getting what we pay for? More
On the Race to Value podcast, Vikas Saini and Shannon Brownlee discuss Dr. Lown's legacy, trust as high-value care, hospital coordination, and much more. More
A recent report from Families USA finds that uninsurance was associated with 44% of Covid-19 infections and 32% of deaths in the US. More
The USPSTF's expanded screening guidelines bring up important questions of screening harms and benefits, generalizing clinical trial results, and the impact of screening on health disparities. More
In JAMA, Michael Chernew and Maximilian Pany argue that a price cap on the higher end of hospital prices would save tens of billions. More
Dr. Vivek Murthy, Biden's pick for surgeon general, was recently found to have accepted significant consulting payments from private companies. Should this disqualify him from the position? More
In a profile in The BMJ, journalist Jeanne Lenzer highlights some of the important times Dr. Lown took a stand, and what this stubbornness cost him. More
How can we remove the barriers and make pharmacists our deprescribing heroes? In their recent piece in Senior Care Pharmacist, Judith Garber and Don Downing create a roadmap for collaboration. More
The final report from the Lancet Commission on Public policy and health in the Trump era offers a bold policy agenda for the Biden administration to undo the damage caused to our nation's health. More
A recent analysis in JAMA finds that overuse in Medicare barely budged from 2014-2018. How can we move further toward value-based care? More
Ever since Covid-19 vaccines have been in development, policy experts and activists have been concerned about equity in vaccine distribution. Now, it is clear that in our haste to get "shots in arms," we are leaving behind many people who are most at risk of Covid-19 infection and death. More
FOR IMMEDIATE RELEASE See Also: Timeline of Dr. Lown’s Life Brookline, MA — Dr. Bernard Lown, pioneering cardiologist, humanitarian, and founder of the Lown Institute, died today at the age of 99. He was a remarkable clinician, scientist, and visionary who will be remembered long into the future. As a scientist, Dr. Lown did seminal […] More
An investigation of a hospital overwhelmed by Covid-19 in Los Angeles shows the vast inequalities between the safety net institutions and other hospitals in the area. More
A little over ten years after the Physician Payments Sunshine Act was passed, how have industry payments to physicians changed? A recent article in Medscape explores the impact of the legislation, obstacles to change, and potential solutions beyond just disclosure. More